Additionally, studies have documented high levels of some TH2 immune cells in COVID-19 patients (e.g. IL-4 and IL-10) [9, 87]; although it has been suggested that these represent normal immune responses to SARS-CoV-2 tissue damage geared toward regulating inflammation and repairing tissue [88]. The gene discussed is IL4; the disease is COVID-19.